Published in
American Association for the Advancement of Science, Science Translational Medicine, 546(12), 2020
DOI: 10.1126/scitranslmed.aaz0463
Links
Tools
Immune landscapes predict chemotherapy resistance and immunotherapy response in acute myeloid leukemia
Journal article published in 2019 by
Jayakumar Vadakekolathu 
,
Amy H. Sullivan,
Mark D. Minden ,
Elena J. Viboch,
Tressa Hood ,
Sarah E. Church ,
Sarah E. Warren,
Stephen Reeder,
Heidi Altmann ,
Thomas H. Smith,
Tasleema Patel ,
Marc Schmitz,
Narmin Ibrahimova,
Andrea Arruda,
Peter J. M. Valk
and other authors.
,
Amy H. Sullivan,
Mark D. Minden ,
Elena J. Viboch,
Tressa Hood ,
Sarah E. Church ,
Sarah E. Warren,
Stephen Reeder,
Heidi Altmann ,
Thomas H. Smith,
Tasleema Patel ,
Marc Schmitz,
Narmin Ibrahimova,
Andrea Arruda,
Peter J. M. Valk
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Dissecting the immune architecture of AML and its influence on therapeutic response identifies patients for whom immunotherapy will be most beneficial.